Las nuevas reglas permiten el reembolso de Teriparatida y Romosozumab para pacientes de alto riesgo, con tarifas establecidas y reclamos solo en hospitales

Factual coreconfirmed by several independent voices

• - ¿Qué? "No hay nada que hacer". “¿Qué quieres decir? ¿Por qué? Seguir leyendo Seguir leyendo

  reliability low1/2 sources

Disputedincompatible versions — to verify

No factual contradiction detected between sources.

Framing by sidesame fact, different words — loaded terms highlighted

No notable framing divergence.

Blind spotwhat one side keeps silent

No blind spot detected: every side covers the same facts.

Sources2 sources cross-checked

Images from the sourcesThe photos each outlet chose to illustrate this story — click to open the article.

• Matichon